Markets worldwide defied expectations in 2024 led by the dominating performance of mega-cap technology stocks known as the ...

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital ...

The San Francisco 49ers are exploring selling a 10% stake at a valuation of more than $9 billion, according to people ...

For the arts institution, which receives only a small portion of its budget from federal funding, the perennial challenge is ...

The Carlyle Group (NASDAQ:CG – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” ...

Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

What will a thin-skinned showman do with an institution central to Washington’s cultural life? One expectation is more ...

From processing giant Stripe to DailyPay, which helps hourly workers get their money faster, 11 payment companies made our ...

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” to simplify the business structure.

The Carlyle Group has announced the listing of its portfolio company Hexaware Technologies, a global IT services company, on the Bombay Stock Exchange and National Stock Exchange in India. The total ...